FDA approves first biosimilar for treatment of cancer
On Sept. 14, the U.S. Food and Drug Administration (FDA) approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple…
Oncology
Addressing the opioid epidemic
Funding and access to care are crucial to solving substance use disorders. The word crisis can be defined in several ways. But when looking…
Recognizing complications in the oncology patient
Quick response includes paying attention to the details. Takeaways: Rapid assessment is key to identifying early complications in the oncology patient. Sense of urgency…
FDA clears patient-assisted mammography system
On Sept. 1, the U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase or decrease…
Ablation of AF improves QOL more than drugs
Ablation of atrial fibrillation (AF) improves quality of life (QOL) more than drugs, according to a study presented on Aug. 29 at the European…
FDA approved first gene therapy in U.S.
“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” said FDA…
Caring for Patients after Transcatheter Aortic Valve Replacement
For many years, surgical aortic valve replacement (SAVR) was the gold-standard treatment for severe, symptomatic aortic stenosis (AS). For eligible patients, this procedure can…
Opening the lines of communication about HPV
When parents resits the HPV (human papillomavirus) vaccine, be prepared to listen and educate. Takeaways Patients and parents may have misconceptions about the purpose…
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell…
Increased cadmium may increase risk of endometrial cancer
Cadmium exposure and endometrial cancer risk: A large midwestern U.S. population-based case-control study. Estrogen-mimicking chemicals, such as cadmium, may be associated with increased susceptibility…
FDA approves treatment for chronic graft versus host disease
August 3, 2017 – The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with…
FDA announces new plan to address nicotine consumption
Protecting American Families: Comprehensive Approach to Nicotine and Tobacco Remarks by Scott Gottlieb, M.D. / Commissioner of Food and Drug Administration July 28, 2017 / White…
FDA approves first biosimilar for treatment of cancer
On Sept. 14, the U.S. Food and Drug Administration (FDA) approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment…
Addressing the opioid epidemic
Funding and access to care are crucial to solving substance use disorders. The word crisis can be defined in several ways. But…
Recognizing complications in the oncology patient
Quick response includes paying attention to the details. Takeaways: Rapid assessment is key to identifying early complications in the oncology patient. Sense…
FDA clears patient-assisted mammography system
On Sept. 1, the U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase…
Ablation of AF improves QOL more than drugs
Ablation of atrial fibrillation (AF) improves quality of life (QOL) more than drugs, according to a study presented on Aug. 29 at…
FDA approved first gene therapy in U.S.
“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,”…
Caring for Patients after Transcatheter Aortic Valve Replacement
For many years, surgical aortic valve replacement (SAVR) was the gold-standard treatment for severe, symptomatic aortic stenosis (AS). For eligible patients, this…
Opening the lines of communication about HPV
When parents resits the HPV (human papillomavirus) vaccine, be prepared to listen and educate. Takeaways Patients and parents may have misconceptions about…
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
On Aug. 17, the U.S. Food and Drug Administration (FDA) approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or…
Increased cadmium may increase risk of endometrial cancer
Cadmium exposure and endometrial cancer risk: A large midwestern U.S. population-based case-control study. Estrogen-mimicking chemicals, such as cadmium, may be associated with…
FDA approves treatment for chronic graft versus host disease
August 3, 2017 – The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult…
FDA announces new plan to address nicotine consumption
Protecting American Families: Comprehensive Approach to Nicotine and Tobacco Remarks by Scott Gottlieb, M.D. / Commissioner of Food and Drug Administration July 28,…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.